SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001553350-19-001194
Filing Date
2019-11-14
Accepted
2019-11-14 17:11:09
Documents
48
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ephs_10q.htm 10-Q 408722
2 CERTIFICATION ephs_ex31z1.htm EX-31 8286
3 CERTIFICATION ephs_ex31z2.htm EX-31.2 8288
4 CERTIFICATION ephs_ex32z1.htm EX-32 3601
5 CERTIFICATION ephs_ex32z2.htm EX-32.2 3623
  Complete submission text file 0001553350-19-001194.txt   2227288

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE stnn-20190930.xml EX-101.INS 307516
7 XBRL SCHEMA FILE stnn-20190930.xsd EX-101.SCH 25882
8 XBRL CALCULATION FILE stnn-20190930_cal.xml EX-101.CAL 44985
9 XBRL DEFINITION FILE stnn-20190930_def.xml EX-101.DEF 87571
10 XBRL LABEL FILE stnn-20190930_lab.xml EX-101.LAB 212196
11 XBRL PRESENTATION FILE stnn-20190930_pre.xml EX-101.PRE 162128
Mailing Address 5490 NOTRE DAME EST MONTREAL A8 H1N 2C4
Business Address 5490 NOTRE DAME EST MONTREAL A8 H1N 2C4 778-980-7187
SKYE LIFE VENTURES LTD. (Filer) CIK: 0001731911 (see all company filings)

IRS No.: 824383947 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55906 | Film No.: 191221535
SIC: 2834 Pharmaceutical Preparations